title: [Ischemia-modified albumin: new marker of myocardial ischemia?].
abstract: The Albumin Cobalt Binding Test is a quantitative in vitro diagnostic test used on human serum that detects ischemia-modified albumin by measuring the cobalt binding capacity of albumin in human serum. Ischemia modified albumin is intended for use in conjunction with ECG and cardiac troponin as an aid to short term risk stratification of patients presenting with chest pain suggestive of cardiac origin. Thus, in patients with chest pain or equivalent symptoms suggestive of cardiac origin, with non-diagnostic ECG and normal troponin, a negative IMA can be used as an aid to rule out acute coronary syndrome (ACS) in low risk patients.
authors: I. interní klinika FN, Hradec Králové. dusekjaroslav@hotmail.com
authors: J
authors: J
authors: Dusek
authors: M
authors: M
authors: Tichý
authors: J
authors: J
authors: Stásek
authors: J
authors: J
authors: Bis
authors: J
authors: J
authors: Gregor
authors: R
authors: R
authors: Pudil
authors: J
authors: J
authors: Vojácek
mesh_terms: D015415:Biomarkers / Q000097:blood; D003035:Cobalt / Q000378:metabolism; D006801:Humans; D017202:Myocardial Ischemia / Q000097:blood / Q000175:diagnosis*; D012709:Serum Albumin / Q000378:metabolism*
chemical_list: D015415:Biomarkers; D012709:Serum Albumin; D003035:Cobalt